https://www.selleckchem.com/pr....oducts/disodium-Crom
00, 95% Confidence Interval (CI) 0.82-1.22). In the sensitivity analysis, compared to the HCVAb D-/R - patients, the HCVAb D+/R - group had a significantly lower risk of CMV infection in the unadjusted analysis (HR = 0.75, 95%CI 0.65-0.85), while this risk difference disappeared after the adjusted analysis (HR = 0.99, 95%CI 0.87-1.14). The incidence of CMV infection was similar in recipients who received HCVAb D + and HCVAb D - KT. Further studies are needed to assess this association in KT from HCV nucleic acid positive d
Like
Comment
Share
